|
|
|
Substance Name: Reteplase [USAN:INN:BAN]
RN: 133652-38-7
UNII: DQA630RIE9
Note
- Mutant form of tissue plasminogen activator used in treatment of myocardial infarct.
Molecular Formula
- C1736-H2653-N499-O522-S22
Molecular Weight
- 39571.4777
Classification Codes
- Cardiovascular Agents
- Fibrin Modulating Agents
- Fibrinolytic Agents
- Hematologic Agents
- Myocardial Infarction Therapy
- Plasminogen Activator
- Plasminogen Activators
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- BM 06.022
- Reteplase
- Reteplase [USAN:INN:BAN]
Synonyms
- 173-L-Serine-174-L-tyrosine-175-L-glutamine-173-527-plasminogen activator (mutant of human tissue-type)
- BM 06.022
- Rapilysin
- Retavase
- Reteplase
- UNII-DQA630RIE9
Systematic Name
- 173-527-Plasminogen activator (human tissue-type), 173-L-serine-174-L-tyrosine-175-L-glutamine-
Registry Numbers
CAS Registry Number
- 133652-38-7
FDA UNII
- DQA630RIE9
System Generated Number
- 0133652387